Managing cardiovascular disease in older adults must be done within a broader context that takes into consideration other issues that become increasingly common with age, like cognitive impairment and ...

The findings align with the trial’s main analysis, but other studies of revascularization in CLTI have come to the opposite ...

A more comprehensive view of bleeding burden can help inform discussions between patients and doctors, a researcher says.

The drug lowered free IL-6 and hs-CRP levels but didn’t affect outcomes, raising doubts about the inflammatory hypothesis.

People who are subjected to both hot weather and air pollution caused by fires at the same time are at higher risk of dying ...

One year after the FDA's approval, Shmuel Chen and Philippe Généreux give an update on the successes and challenges in this ...

Tirzepatide (Mounjaro; Lilly) appears to reduce major cardiovascular events beyond what can be achieved with placebo for ...

Enrollment by Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital marks a significant milestone in the ...

The Centers for Medicare & Medicaid Services is weighing whether to cover TAVI in asymptomatic severe aortic stenosis, as ...

Delivery of preventive cardiovascular care seems to improve for patients covered by Medicaid when accountable care ...

Three countries with different systems achieved similar levels of control, indicating that efforts to lessen CV risk should ...

With an influential tenure in industry followed by a fruitful post-retirement, Woodall is remembered for his leadership and ...